🔴 Prodia Diagnostic Line is trading 3.85% down after first-half loss and 51.89% revenue drop

Prodia Diagnostic Line is trading at IDR 200.00 (-3.85%) as selling continues after weak first-half 2026 results released July 30.

• Revenue fell 51.89% year over year to Rp13.70 billion, while the company reported an Rp8.84 billion net loss.
• The stock declined from IDR 246.00 on September 10 to IDR 200.00 on September 21.
• The September 1 product-expansion announcement did not offset earnings concerns; coverage confirmed the first-half loss and sharply lower clinical-chemistry product revenue.